Parenteral Iron Therapy: Safety and Efficacy-Reference-Cited by-同舟云学术

Parenteral Iron Therapy: Safety and Efficacy

Published:1999-08 Issue:4 Volume:12 Page:237-242
ISSN:0894-0959
Container-title:Seminars in Dialysis
language:en
Short-container-title:Seminars in Dialysis

Author:

Besarab Anatole¹

Affiliation:

1. Division of Nephrology and Hypertension, Department of Medicine, Henry Ford Hospital, Detroit, Michigan

Publisher

Wiley

Subject

Nephrology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1525-139X.1999.99028.x

Reference92 articles.

1. A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects

2. Treatment of the Anemia of Progressive Renal Failure with Recombinant Human Erythropoietin

3. USA Multicenter Clinical Trial with Recombinant Human Erythropoietin (Amgen)

4. Early dosing practices and effectiveness of recombinant human erythropoietin

5. U.S. Renal Data System (USRDS):Annual Data Report. Bethesda MD: National Institutes of Health National Institute of Diabetes and Digestive and Kidney Disease April 1996

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous Iron and the Risk of Infection in End-Stage Renal Disease Patients;Seminars in Dialysis;2008-10-09

2. HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Intravenous Iron Therapy in End-Stage Renal Disease;Seminars in Dialysis;2006-07-18

3. Non-Transferrin-Bound Iron in the Serum of Hemodialysis Patients Who Receive Ferric Saccharate: No Correlation to Peroxide Generation;Journal of the American Society of Nephrology;2004-06-01

4. Transient increase of the labile iron pool in HepG2 cells by intravenous iron preparations;European Journal of Biochemistry;2003-09

5. Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron–saccharate administration;Nephrology Dialysis Transplantation;2000-11-01